MTOR and gout: A recent study using a translational approach from ex vivo to in vitro and back to in vivo showed that ex vivo immune cells from gout patients exhibit higher relative gene expression of the mTOR pathway as compared to healthy controls, with monocytes being the most prominent mTOR expressers [38].